Survival Odds to Minimize Risk Heterogeneity Bias in Heart Failure Trials: Application to Dapagliflozin

Authors

Institutions

Publication Details

Journal
Circulation Heart Failure
Published
2025-10-31
DOI
https://doi.org/10.1161/circheartfailure.125.013496
Primary Topic
Advanced Causal Inference Techniques
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Survival Odds to Minimize Risk Heterogeneity Bias in Heart Failure Trials: Application to Dapagliflozin

Melinda Poole, Brian Lee Claggett, Robin Myte, Dustin J. Little et al.
Circulation Heart Failure
Advanced Causal Inference Techniques
article

Survival Odds to Minimize Risk Heterogeneity Bias in Heart Failure Trials: Application to Dapagliflozin

Melinda Poole, Brian Lee Claggett, Robin Myte, Dustin J. Little, John J.V. McMurray, Alasdair Henderson, Samvel B. Gasparyan, Scott David Solomon, Andrea Mattsson, Per Nyström
article en

Abstract

No abstract available for this paper.
Circulation Heart FailureVol. 18(12)
Brigham and Women's Hospital (US), British Heart Foundation (GB), AstraZeneca (Brazil) (BR), AstraZeneca (Finland) (FI), AstraZeneca (Spain) (ES)
Openalex Percentile: Top 71%
Advanced Causal Inference Techniques
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.